Sigma Planning Corp Iovance Biotherapeutics, Inc. Transaction History

Sigma Planning Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$28.04 - $50.26 $209,206 - $374,989	-7,461 Closed	0 $0
Q3 2020 Nov 03, 2020	SELL	$27.75 - $36.3 $28,388 - $37,134	-1,023 Reduced 12.06%	7,461 $246,000
Q2 2020 Jul 31, 2020	BUY	$27.21 - $41.0 $20,652 - $31,119	759 Added 9.83%	8,484 $233,000
Q1 2020 May 01, 2020	SELL	$19.54 - $38.85 $6,663 - $13,247	-341 Reduced 4.23%	7,725 $231,000
Q4 2019 Feb 03, 2020	BUY	$17.95 - $29.41 $144,784 - $237,221	8,066 New	8,066 $223,000

343

247M

2.51M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $589M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.